Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Satsuma Pharmaceuticals I...

    NASDAQ: STSA · Real-Time Price · USD
    1.10
    0.00 (0.00%)
    At close: Jun 07, 2023, 10:00 PM

    Satsuma Pharmaceuticals Statistics

    Share Statistics

    Satsuma Pharmaceuticals has 33.15M shares outstanding. The number of shares has increased by 0% in one year.

    Shares Outstanding

    n/a
    		 33.15M

    Shares Change (YoY)

    n/a
    		 0%

    Shares Change (QoQ)

    n/a
    		 0%

    Owned by Institutions (%)

    n/a
    		 n/a

    Shares Floating

    n/a
    		 15.2M

    Failed to Deliver (FTD) Shares

    n/a
    		 238

    FTD / Avg. Volume

    n/a
    		 0.02%

    Short Selling Information

    Short Interest

    n/a
    		 n/a

    Short % of Shares Out

    n/a
    		 n/a

    Short % of Float

    n/a
    		 n/a

    Short Ratio (days to cover)

    n/a
    		 n/a

    Valuation Ratios

    The PE ratio is -0.42 and the forward PE ratio is null. Satsuma Pharmaceuticals's PEG ratio is -0.02.

    PE Ratio

    n/a
    		 -0.42

    Forward PE

    n/a
    		 n/a

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 n/a

    PB Ratio

    n/a
    		 -0.14

    P/FCF Ratio

    n/a
    		 -0.55

    PEG Ratio

    n/a
    		 -0.02
    Financial Ratio History

    Enterprise Valuation

    Satsuma Pharmaceuticals has an Enterprise Value (EV) of 12.53M.

    EV / Sales

    n/a
    		 0

    EV / EBITDA

    n/a
    		 -0.21

    EV / EBIT

    n/a
    		 -0.24

    EV / FCF

    n/a
    		 -0.24

    Financial Position

    The company has a current ratio of 6.75, with a Debt / Equity ratio of 0.

    Current Ratio

    n/a
    		 6.75

    Quick Ratio

    n/a
    		 6.75

    Debt / Equity

    n/a
    		 0

    Debt / EBITDA

    n/a
    		 n/a

    Debt / FCF

    n/a
    		 n/a

    Interest Coverage

    n/a
    		 -5457.46

    Financial Efficiency

    Return on Equity is 32.66% and Return on Invested Capital is 33.09%.

    Return on Equity

    n/a
    		 32.66%

    Return on Assets

    n/a
    		 -125.89%

    Return on Invested Capital

    n/a
    		 33.09%

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 $-2,766,520

    Employee Count

    n/a
    		 25

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 -892K

    Effective Tax Rate

    n/a
    		 1.27%

    Stock Price Statistics

    The stock price has increased by 0% in the last 52 weeks. The beta is 0.1, so Satsuma Pharmaceuticals's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.1

    52-Week Price Change

    n/a
    		 n/a

    50-Day Moving Average

    n/a
    		 0.97

    200-Day Moving Average

    n/a
    		 2.38

    Relative Strength Index (RSI)

    n/a
    		 60.82

    Average Volume (20 Days)

    n/a
    		 1,106,610

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 n/a

    Operating Income

    n/a
    		 -70.95M

    Net Income

    n/a
    		 -69.16M

    EBITDA

    n/a
    		 -58.31M

    EBIT

    n/a
    		 -70.04M

    Earnings Per Share (EPS)

    n/a
    		 -2.16
    Full Income Statement

    Balance Sheet

    The company has 16.43M in cash and 138K in debt, giving a net cash position of 16.29M.

    Cash & Cash Equivalents

    n/a
    		 16.43M

    Total Debt

    n/a
    		 138K

    Net Cash

    n/a
    		 16.29M

    Retained Earnings

    n/a
    		 -211.79M

    Total Assets

    n/a
    		 43.48M

    Working Capital

    n/a
    		 37.54M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -51.52M and capital expenditures -472K, giving a free cash flow of -51.99M.

    Operating Cash Flow

    n/a
    		 -51.52M

    Capital Expenditures

    n/a
    		 -472K

    Free Cash Flow

    n/a
    		 -51.99M

    FCF Per Share

    n/a
    		 -1.62
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    STSA pays an annual dividend of $1.35, which amounts to a dividend yield of 6.8%.

    Dividend Per Share

    n/a
    		 $1.35

    Dividend Yield

    n/a
    		 6.8%

    Dividend Growth (YoY)

    n/a
    		 0%

    Payout Ratio

    n/a
    		 -67.84%

    Earnings Yield

    n/a
    		 -239.96%

    FCF Yield

    n/a
    		 -180.37%
    Dividend Details

    Analyst Forecast

    Currently there are no analyst rating for STSA.

    Price Target

    n/a
    		 n/a

    Price Target Difference

    n/a
    		 n/a

    Analyst Consensus

    n/a
    		 n/a

    Analyst Count

    n/a
    		 n/a
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 -7.38

    Piotroski F-Score

    n/a
    		 2

    Add to Watchlist